# Summit Biosciences Inc. – FDA Inspection, Feb 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/fbf78c84-7d7e-4694-9f67-ee101159342d
Source feed: FDA_Inspections

> FDA inspection 1261583 of Summit Biosciences Inc., February 21, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261583
- Company Name: Summit Biosciences Inc.
- Inspection Date: 2025-02-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Cincinnati District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1218227 - 2023-09-14](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/4dfd068f-13de-4321-897b-877c72d3592b)
- FDA Inspection 1121348 - 2020-02-04
- FDA Inspection 1018004 - 2017-06-23
- FDA Inspection 933643 - 2015-06-18
- FDA Inspection 868633 - 2014-02-28

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/ucheabuchi-c-chudi-nwankwor/18b01d08-3cfd-4ace-97b2-5f54b6427661)

Company: https://www.keypedia.com/companies/summit-biosciences-inc/2dadddc5-06ce-43be-914b-1b6e9a76e976

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22
